☆ 4.7 Article

CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer

BRITISH JOURNAL OF CANCER (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model

Pan Li et al.

Summary: This study investigates the potential of a combination therapy involving an anti-IL-8 antibody and an anti-PD-1 antibody for treating pancreatic ductal adenocarcinoma (PDAC). The results show that the combination treatment enhances the antitumor activity and activates the innate immune response in the tumor microenvironment. CD16+ myeloid cells, particularly granulocytes, are identified as the main target of IL-8. These findings provide a basis for further clinical testing of this combination therapy in PDAC treatment and highlight the role of peripherally derived myeloid cells in promoting the antitumor response of T cells.

CANCER LETTERS (2022)

添加到收藏夹

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy

Alvaro Teijeira et al.

Summary: High levels of IL8 in cancer patients can accurately predict non-response to immunotherapy, as IL8 plays a key role in attracting and modulating neutrophils and macrophages to promote cancer progression and metastasis. Blocking IL8 or its receptors is being investigated as a potential therapeutic strategy in combination with immunotherapy.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Tumor-associated macrophages in immunotherapy

Shijia Yan et al.

Summary: Tumor-associated macrophages (TAMs) play essential roles in tumor progression and metastasis by promoting angiogenesis, immunosuppression, and fibrotic activities. While immunotherapy has shown promising results in eradicating cancer cells by activating the innate immune system, the tumor-suppressive environment is crucial in cancer relapse.

FEBS JOURNAL (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer

Jingwei Shi et al.

Summary: IL-4 and IL-13 are pleiotropic Th2 cytokines involved in immune responses and have been found to play a role in oncogenesis and tumor progression. Their effects on tumor cells are mediated through specific receptors, with IL-4R alpha/IL-13R alpha 1 being the main target in tumors. Understanding the implications of these cytokines and their receptors in pancreatic cancer helps in developing potential new diagnostic and therapeutic strategies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Oncology

Uncoupled biological and chronological aging of neutrophils in cancer promotes tumor progression

Laura A. Mittmann et al.

Summary: The study reveals that signals released during early tumor growth accelerate the biological aging of circulating neutrophils, leading to the decoupling of biological aging from chronological aging of these immune cells. This accumulation of highly reactive neutrophils in malignant lesions endows them with potent protumorigenic functions, promoting tumor progression. Interference with this aberrant process could potentially provide a novel strategy for cancer immunotherapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Article Immunology

The Ratio of IP10 to IL-8 in Plasma Reflects and Predicts the Response of Patients With Lung Cancer to Anti-PD-1 Immunotherapy Combined With Chemotherapy

Liangliang Wu et al.

Summary: The ratio of IP-10 to IL-8 in peripheral blood can serve as a biomarker for predicting treatment response and survival in patients receiving immune-combined chemotherapy for lung cancer and multiple cancers. The combination of IL-8 and IP-10 as predictors shows improved specificity and sensitivity compared to using them alone, with potential broad clinical applications in treating intractable neoplasms.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

Humanized Mouse Models for the Advancement of Innate Lymphoid Cell-Based Cancer Immunotherapies

Nina B. Horowitz et al.

Summary: Innate lymphoid cells (ILCs) play an important role in antitumor immunity, but their behavior in the context of cancer is not fully understood. Humanized mouse models serve as excellent tools for studying these pathways and interactions between ILCs and tumors.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy

Ruiyu Li et al.

Summary: By identifying a novel molecular subtype, Immune Class, in PDAC patients, we found it to be an independent favorable prognostic factor for overall survival. The Immune Class, in combination with tumor and stroma classifications, had a cumulative effect on the prognostic stratification of PDAC.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Oncology

Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer

Carmine Carbone et al.

Summary: Intratumoral injection of IMO-2125 triggers immune response against both local and distant tumors, showing potent antitumor activity in high immunogenic subtype of pancreatic cancer models. Moreover, the combination of intratumoral IMO-2125 with systemic anti-PD1 demonstrates strong antitumor effects even in pancreatic cancer models with low immunogenic potential. This study provides a rationale for translating this strategy into clinical practice.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Turning cold tumors into hot tumors by improving T-cell infiltration

Yuan-Tong Liu et al.

Summary: Immunotherapy, particularly through immune checkpoint inhibitors, has significantly improved the treatment of malignant tumors by enhancing T cell infiltration into tumors. Understanding the mechanisms underlying cold tumors, which lack T cell infiltration, is crucial to improving immunotherapy efficacy. Strategies to transform cold tumors into hot tumors and increase T cell infiltration are discussed, along with the potential of nanomedicines in enhancing tumor immunotherapy.

THERANOSTICS (2021)

添加到收藏夹

Article Oncology

Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer

Raffaela Santoro et al.

MOLECULAR CANCER THERAPEUTICS (2020)

添加到收藏夹

Editorial Material Oncology

Patient-derived xenograft models-the future of personalised cancer treatment

Jenna Bhimani et al.

BRITISH JOURNAL OF CANCER (2020)

添加到收藏夹

Article Oncology

Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing Immunotherapy

Wai Nam Liu et al.

CANCERS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I

Keisuke Yamamoto et al.

NATURE (2020)

添加到收藏夹

Editorial Material Biochemistry & Molecular Biology

IL-8 and cancer prognosis on immunotherapy

Ziad Bakouny et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors

Kurt A. Schalper et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade

Kobe C. Yuen et al.

NATURE MEDICINE (2020)

添加到收藏夹

Review Medicine, Research & Experimental

Innovations, challenges, and minimal information for standardization of humanized mice

Renata Stripecke et al.

EMBO MOLECULAR MEDICINE (2020)

添加到收藏夹

Article Immunology

A Neutrophil Timer Coordinates Immune Defense and Vascular Protection

Jose M. Adrover et al.

IMMUNITY (2019)

添加到收藏夹

Review Oncology

Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features

Eva Karamitopoulou

BRITISH JOURNAL OF CANCER (2019)

添加到收藏夹

Article Oncology

Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial

Eileen M. O'Reilly et al.

JAMA ONCOLOGY (2019)

添加到收藏夹

Article Cell Biology

Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer

Diletta Di Mitri et al.

CELL REPORTS (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease

Dea Filippini et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications

Xiaomeng Liu et al.

MOLECULAR CANCER (2019)

添加到收藏夹

Article Oncology

MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity

Raffaela Santoro et al.

ANTICANCER RESEARCH (2018)

添加到收藏夹

Review Immunology

Pancreatic Ductal Adenocarcinoma: A Strong imbalance of Good and Bad immunological Cops in the Tumor Microenvironment

Etienne D. Foucher et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

Review Immunology

Humanized Mice for the Study of Immuno-Oncology

Philippe De La Rochere et al.

TRENDS IN IMMUNOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Cxcr1 mediates recruitment of neutrophils and supports proliferation of tumor-initiating astrocytes in vivo

Davalyn Powell et al.

SCIENTIFIC REPORTS (2018)

添加到收藏夹

Article Cell Biology

TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma

Tim D. D. Somerville et al.

CELL REPORTS (2018)

添加到收藏夹

Article Biochemical Research Methods

Salmon provides fast and bias-aware quantification of transcript expression

Rob Patro et al.

NATURE METHODS (2017)

添加到收藏夹

Article Oncology

Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment

Daria Marley Kemp et al.

ONCOTARGET (2017)

添加到收藏夹

Article Oncology

Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy

Andrea Facciabene et al.

ONCOIMMUNOLOGY (2017)

添加到收藏夹

Article Oncology

Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors

Lucy Ireland et al.

CANCER RESEARCH (2016)

添加到收藏夹

Article Oncology

Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)

Carlos Alfaro et al.

CLINICAL CANCER RESEARCH (2016)

添加到收藏夹

Review Biochemistry & Molecular Biology

The CXCL8-CXCR1/2 pathways in cancer

Qian Liu et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter Bailey et al.

NATURE (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

Maxim V. Kuleshov et al.

NUCLEIC ACIDS RESEARCH (2016)

添加到收藏夹

Article Oncology

CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma

Timothy Chao et al.

CANCER IMMUNOLOGY RESEARCH (2016)

添加到收藏夹

Review Immunology

HLA Mismatching Strategies for Solid Organ Transplantation - A Balancing Act

Andrea A. Zachary et al.

FRONTIERS IN IMMUNOLOGY (2016)

添加到收藏夹

Article Cell Biology

Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy

Steven L. Highfill et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

添加到收藏夹

Article Pharmacology & Pharmacy

Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor

R. Bertini et al.

BRITISH JOURNAL OF PHARMACOLOGY (2012)

添加到收藏夹

Article Medicine, General & Internal

Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

添加到收藏夹

Article Oncology

Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Richard E. Royal et al.

JOURNAL OF IMMUNOTHERAPY (2010)

添加到收藏夹

Article Pharmacology & Pharmacy

Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events

Mieke Gouwy et al.

MOLECULAR PHARMACOLOGY (2008)

添加到收藏夹

Review Immunology

Humanized mice in translational biomedical research

Leonard D. Shultz et al.

NATURE REVIEWS IMMUNOLOGY (2007)

添加到收藏夹

Article Immunology

Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes

R Bonecchi et al.

JOURNAL OF IMMUNOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.